Literature DB >> 7721806

The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization.

P Ancian1, G Lambeau, M G Mattéi, M Lazdunski.   

Abstract

Secretory phospholipases A2 (sPLA2) are structurally related enzymes found in mammals as well as in insect and snake venoms. They have been associated with several physiological, pathological, and toxic processes. Some of these effects are apparently linked to the existence of specific receptors for both venom and mammalian sPLA2s. We report here the molecular cloning and expression of one of these sPLA2 receptors from human kidney. Two transcripts were detected. One encodes for a transmembrane form of the sPLA2 receptor and the other one is an alternatively processed transcript, caused by polyadenylation occurring at a site within an intron in the C terminus part of the transcriptional unit. This transcript encodes for a shortened secreted soluble sPLA2 receptor lacking the coding region for the transmembrane segment. Quantitative polymerase chain reaction experiments indicate a 1.6:1 ratio between the levels of transcripts encoding for the membrane-bound and soluble forms of the receptor, respectively. Soluble and membrane-bound human sPLA2 receptors both bind sPLA2 with high affinities. However, the binding properties of the human receptors are different from those obtained with the rabbit membrane-bound sPLA2 receptor. The 180-kDa human sPLA2 receptor gene has been mapped in the q23-q24 bands of chromosome 2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721806     DOI: 10.1074/jbc.270.15.8963

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Affinity enhancement by multivalent lectin-carbohydrate interaction.

Authors:  R T Lee; Y C Lee
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Binding and internalization of extracellular type-I phospholipase A2 in uterine stromal cells.

Authors:  G P Rossini; J M Fayard; C Tessier; C Laugier
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

Review 3.  Alternative poly(A) site selection in complex transcription units: means to an end?

Authors:  G Edwalds-Gilbert; K L Veraldi; C Milcarek
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

Review 4.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

5.  Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper.

Authors:  S Lizano; B Lomonte; J W Fox; J M Gutiérrez
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 6.  Unmet challenges in membranous nephropathy.

Authors:  David J Salant
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

Review 7.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

8.  Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.

Authors:  Yu-Huei Liu; Cheng-Hsu Chen; Shih-Yin Chen; Ying-Ju Lin; Wen-Ling Liao; Chang-Hai Tsai; Lei Wan; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-10-11       Impact factor: 8.410

9.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

10.  Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report.

Authors:  Laith Al-Rabadi; Rivka Ayalon; Ramon G Bonegio; Jennifer E Ballard; Alan M Fujii; Joel M Henderson; David J Salant; Laurence H Beck
Journal:  Am J Kidney Dis       Date:  2015-12-29       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.